Wyeth in Talks to Acquire Crucell

Biopharmaceutical company Crucell (Leiden, Netherlands) says it is in friendly discussions with Wyeth (Madison, NJ), that may lead to a merger with Wyeth. These discussions are at a preliminary stage and there is no certainty that they will result in a transaction, Crucell says. Wyeth if offering to pay up to $1.35 billion to buy Crucell, say press reports. French pharmaceutical company Sanofi-Aventis (Paris) is also expected to make a rival bid for Crucell, reports...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers